Mycamine

Mycamine (micafungin) is a systemic antimycotic indicated for invasive candidiasis, oesophageal candidiasis and prophylaxis of candida infection.

Mycamine inhibits the synthesis of 1,3-B-D-glucan, an essential component of the fungal cell wall.

Treatment must be initiated by a specialist and the decision to use Mycamine should take into account a potential risk of developing liver tumours. Liver function must be carefully monitored throughout treatment.

Treatment indications:

  • Invasive candidiasis in adults and children.
  • Oesophageal candidiasis in patients aged >16 years where iv therapy is appropriate.
  • Prophylaxis of candida infection in adults and children undergoing allogeneic haematopoietic stem cell transplantation or patients expected to have neutropenia for >10 days.

View Mycamine drug record

Further information: Astellas

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Topical Steroids, Comparison of Potencies and Formulations

Topical Steroids, Comparison of Potencies and Formulations

Strengths and formulations of topical steroids.

Topical Steroids, Potential Skin Sensitisers as Ingredients

Topical Steroids, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in topical steroids.

Correct vitamin D deficiency to reduce COPD exacerbations, say researchers

Correct vitamin D deficiency to reduce COPD exacerbations, say researchers

Vitamin D supplements could nearly halve the rate of...

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Launch of new SGLT2 inhibitor increases choice in diabetes prescribing

Ertugliflozin (Steglatro) is a sodium glucose co-transporter...